Skip to main content

Articles

Page 16 of 335

  1. This study aimed to identify new pyroptosis-associated tumor antigens for use in mRNA vaccines and the screening of sensitive LUAD populations suitable for vaccination. The association between tumor immune inf...

    Authors: Fang Zhou, Meng Wang, Zheng Wang, Wei Li and Xike Lu
    Citation: BMC Cancer 2024 24:28
  2. (1) This study aims to identify distinct serum metabolites in gastric cancer patients compared to healthy individuals, providing valuable insights into postoperative efficacy evaluation and monitoring of gastr...

    Authors: Tong Qu, Shaopeng Zhang, Shaokang Yang, Shuang Li and Daguang Wang
    Citation: BMC Cancer 2024 24:27
  3. Epigenetic alterations contribute greatly to the development and progression of colorectal cancer, and effect of aberrant miR-622 expression is still controversial. This study aimed to discover miR-622 regulat...

    Authors: Yuehong Chen, Feng Liu, Xinhua Chen, Wenyi Li, Kejun Li, Hailang Cai, Shunyi Wang, Honglei Wang, Ke Xu, Chenxi Zhang, Shengzhi Ye, Yunhao Shen, Tingyu Mou, Shumin Cai, Jianwei Zhou and Jiang Yu
    Citation: BMC Cancer 2024 24:26
  4. The evidence about the effects of trace elements on overall survival(OS) of patients with esophageal squamous cell carcinoma(ESCC) is limited. This study aims to evaluate mixed effects of plasma trace elements...

    Authors: Kaili Yu, Shuang Liu, Zheng Lin, Jianyu Song, Qiaoyan Zeng, Jinsong Zhou, Juwei Zhang, Suhong Zhang, Jianbo Lin, Zhisheng Xiang and Zhijian Hu
    Citation: BMC Cancer 2024 24:24
  5. Pathologists are currently supposed to be aware of both domestic and international guidelines for breast cancer diagnosis, but it is unclear how successfully these guidelines have been integrated into routine ...

    Authors: Xuemin Xue, Lei Guo, Changyuan Guo, Lin Li, Lin Yang, Xin Wang, Wei Rao, Pei Yuan, Jiali Mu, Jiangtao Li, Bingning Wang, Quan Zhou, Wentao Yang, Yueping Liu, Weicheng Xue, Rujing Jia…
    Citation: BMC Cancer 2024 24:23
  6. To evaluate the efficacy and safety of regorafenib monotherapy or in combination with immune-checkpoint inhibitor while treating Chinese patients with metastatic colorectal cancer (mCRC): a real-world study.

    Authors: Wang Qu, Zimin Liu, Xiaobing Chen, Bo Liu, YunBo Zhao, Hao Yan, Xiujuan Qu, Shengmian Li, Aimin Zang, Yongkun Sun, Liangjun Zhu and Aiping Zhou
    Citation: BMC Cancer 2024 24:22
  7. Currently, the value of oral selective estrogen receptor degraders (SERDs) for hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (aBC) after p...

    Authors: Xiewei Huang, Yushuai Yu, Shiping Luo, Wenfen Fu, Jie Zhang and Chuangui Song
    Citation: BMC Cancer 2024 24:21

    The Correction to this article has been published in BMC Cancer 2024 24:205

  8. PD-L1, a target of immune checkpoint blockade, has been proven to take the role of an oncogene in most human tumors. However, the role of PD-L1 in human pan-cancers has not yet been fully investigated.

    Authors: Yongfeng Wang, Hong Jiang, Liangyin Fu, Ling Guan, Jiaxin Yang, Jingyao Ren, Fangyu Liu, Xiangyang Li, Xuhui Ma, Yonghong Li and Hui Cai
    Citation: BMC Cancer 2024 24:20
  9. GBM is the most frequent malignant primary brain tumor in humans. The CLEC19A is a member of the C-type lectin family, which has a high expression in brain tissue. Herein, we sought to carry out an in-depth analy...

    Authors: Fatemeh Mohajerani, Zahra Moazezi Tehrankhah, Saeid Rahmani, Nastaran Afsordeh, Sajad Shafiee, Mohammad Hossein Pourgholami, Bahram M. Soltani and Majid Sadeghizadeh
    Citation: BMC Cancer 2024 24:19
  10. Peripheral T-cell lymphoma (PTCL) refers to a heterogenous group of T-cell neoplasms with poor treatment responses and survival times. Canine PTCL clinically and immunophenotypically resembles the most common ...

    Authors: Eileen Owens, Lauren Harris, Adam Harris, Janna Yoshimoto, Robert Burnett and Anne Avery
    Citation: BMC Cancer 2024 24:18
  11. Although the side effects of chemotherapy are frequently described in research studies, there is little evidence on how common they are in everyday clinical care. This study’s goal was to assess the most preva...

    Authors: Farah Choulli, Hassan Abdelilah Tafenzi, Faiçal EL Hattimy, Mohamed Khaled Choulli and Rhizlane Belbaraka
    Citation: BMC Cancer 2024 24:17
  12. The optimal treatment for metastatic colorectal cancer (mCRC) after the second line is still controversial. Regorafenib has been the standard of care in this setting as it improved overall survival (OS) compar...

    Authors: Elif Åženocak Taşçı, BaÅŸak Oyan, Özlem Sönmez, Arda UlaÅŸ Mutlu, Muhammed Mustafa Atcı, Abdullah Sakin, Ä°rem Öner, Havva YeÅŸil Çınkır, Melek Karakurt Eryılmaz, Dilek ÇaÄŸlayan, Onur Yazdan Balçık, Nail Paksoy, Senem Karabulut, Derya Kıvrak Salim, Cemil Bilir, Miraç Özen…
    Citation: BMC Cancer 2024 24:16

    The Correction to this article has been published in BMC Cancer 2024 24:114

  13. Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 2 (APOBEC2) is associated with nucleotide alterations in the transcripts of tumor-related genes which are contributed to carcinogenesis. Expressi...

    Authors: Lipan Wei, Xiuqian Wu, Lan Wang, Ling Chen, Xuejun Wu, Tiantian Song, Yuanyuan Wang, Wenjun Chang, Aizhen Guo, Yongdong Niu and Haihua Huang
    Citation: BMC Cancer 2024 24:15
  14. The residual cancer burden index (RCB) was proposed as a response evaluation criterion in breast cancer patients treated with Neoadjuvant Chemotherapy (NAC). This study evaluated the relevance of RCB with repl...

    Authors: Xin Xu, Wei Zhao, Cuicui Liu, Yongsheng Gao, Dawei Chen, Meng Wu, Chao Li, Xinzhao Wang, Xiang Song, Jinming Yu, Zhaoyun Liu and Zhiyong Yu
    Citation: BMC Cancer 2024 24:13
  15. This systematic review and meta-analysis aimed to determine the potential value of neutrophil to lymphocyte ratio (NLR) as an assessment tool in the clinical distinction between uterine sarcoma and uterine lei...

    Authors: Fatemeh Tabatabaei, Saghar Babadi, Shima Nourigheimasi, Arshin Ghaedi, Monireh Khanzadeh, Aida Bazrgar, Morad Kohandel Gargari and Shokoufeh Khanzadeh
    Citation: BMC Cancer 2024 24:12
  16. The aim of this study was to investigate the clinical, imaging and pathological features of extraskeletal osteosarcoma (EOS) and to improve the understanding of this disease and other similar lesions.

    Authors: Xiao-chun Wang, Ling Zhang, Jiong-bin Lin, Xiao-yao Huang, Jing-hong Liang, Jian-ping Zhong, Ji-dong Peng and Jun-yuan Zhong
    Citation: BMC Cancer 2024 24:11
  17. Nervous system toxicity (NST) is one of the most frequent and dangerous side effects of chimeric antigen receptor T-cell (CAR-T) therapy, which is an effective treatment for related tumors in most relapsed/ref...

    Authors: Xiayang Ren, Guanmin Zhang, Guohui Li and Yanfeng Wang
    Citation: BMC Cancer 2024 24:10
  18. The use of taxanes following the first trimester of pregnancy is endorsed by current clinical guidelines. However, evidence regarding their safety in terms of obstetric and neonatal outcomes is limited.

    Authors: Alejandro Aranda-Gutierrez, Ana S. Ferrigno Guajardo, Bryan F. Vaca-Cartagena, David G. Gonzalez-Sanchez, Arantxa Ramirez-Cisneros, Andrea Becerril-Gaitan, Hatem A. Azim Jr and Cynthia Villarreal-Garza
    Citation: BMC Cancer 2024 24:9
  19. The incidence of prostate cancer (PCa), the most prevalent malignancy, is currently at the forefront. RNA modification is a subfield of the booming field of epigenetics. To date, more than 170 types of RNA mod...

    Authors: Xuming Zhou, Keqiang Chai, Hezhen Zhu, Cong Luo, Xiaofeng Zou, Junrong Zou and Guoxi Zhang
    Citation: BMC Cancer 2024 24:8
  20. Anlotinib is a multi-target tyrosine kinase inhibitor (TKI) targeting the vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), fibroblast growth factor receptor...

    Authors: Shuangshuang Zhao, Minmin Zhang, Qing Zhang, Jingjun Wu and Hui Dai
    Citation: BMC Cancer 2024 24:6
  21. Long non-coding RNA (lncRNA) H19 has gained significant recognition as a pivotal contributor to the initiation and advancement of gynecologic cancers, encompassing ovarian, endometrial, cervical, and breast ca...

    Authors: Majid Ghasemian, Mojtaba Zehtabi, Mahrokh Abouali Gale Dari, Fatemeh Khojasteh Pour, Ghasem Azizi Tabesh, Farideh Moramezi, Razieh Mohammad Jafari, Mojgan Barati, Shahab Uddin and Maryam Farzaneh
    Citation: BMC Cancer 2024 24:4
  22. Preclinical in vivo cancer models are essential tools for investigating tumor progression and response to treatment prior to clinical trials. Although treatment modalities are regularly assessed in mice upon t...

    Authors: Anais Oudin, Pilar M. Moreno-Sanchez, Virginie Baus, Simone P. Niclou and Anna Golebiewska
    Citation: BMC Cancer 2024 24:3
  23. Although substantial efforts have been made to build molecular biomarkers to predict radiation sensitivity, the ability to accurately stratify the patients is still limited. In this study, we aim to leverage l...

    Authors: Alona Kolnohuz, Leyla Ebrahimpour, Sevinj Yolchuyeva and Venkata S. K. Manem
    Citation: BMC Cancer 2024 24:2
  24. This research designeded to: 1. Analyze the efficacy and safety of Palbociclib treatment in HR-positive and HER2-negative (HR + /HER2-) metastatic breast cancer(MBC) patients. 2. Establish and validate a nomog...

    Authors: Wei Wang, Wenqian Lei, Ziru Fang, Ruiyuan Jiang and Xiaojia Wang
    Citation: BMC Cancer 2024 24:1
  25. Previous randomized studies have shown a survival benefit of using regorafenib but a high rate of adverse events in unresectable colorectal cancer patients. To reduce these adverse events and improve the toler...

    Authors: Masayuki Nakashima, Kan Li, Qichen Chen, Sajith de Silva, Hal Li, Koji Kawakami, Qingyi Wei, Sheng Luo and Hong Zhao
    Citation: BMC Cancer 2023 23:1268
  26. Head and neck squamous carcinoma (HNSC) poses a significant public health challenge due to its substantial morbidity. Nevertheless, despite advances in current treatments, the prognosis for HNSC remains unsati...

    Authors: Juanli Xing, Yanan Gu, Yichen Song, Qi Liu, Qian Chen, Peng Han, Zhen Shen, Huajing Li, Shaoqiang Zhang, Yanxia Bai, Junchi Ma and Fang Sui
    Citation: BMC Cancer 2023 23:1267
  27. Shared decision-making has become of increased importance in choosing the most suitable treatment strategy for early rectal cancer, however, clinical decision-making is still primarily based on physicians’ per...

    Authors: Lisanne J. H. Smits, Annabel S. van Lieshout, Saskia Debets, Sacha Spoor, Leon M. G. Moons, Koen C. M. J. Peeters, Stefan E. van Oostendorp, Olga C. Damman, Rien J. P. A. Janssens, Wytze Lameris, Nicole C. T. van Grieken and Jurriaan B. Tuynman
    Citation: BMC Cancer 2023 23:1266
  28. To develop a clinical model for predicting high axillary nodal burden in patients with early breast cancer by integrating ultrasound (US) and clinicopathological features.

    Authors: Lei Yang, Yifan Gu, Bing Wang, Ming Sun, Lei Zhang, Lei Shi, Yanfei Wang, Zheng Zhang and Yifei Yin
    Citation: BMC Cancer 2023 23:1264
  29. Gastric cancer is a clinically common tumor, showing an upward trend of both incidence and mortality. GRB7 has been identified as a vital regulator in tumor progression. This study aims to uncover the biologic...

    Authors: Guomin Zhu, Hu Cai, Qiang Xiao, Shukun Zeng, Xiaohua Jiang and Donglan Liu
    Citation: BMC Cancer 2023 23:1262
  30. Cancer is becoming a major public health problem globally and a leading cause of death in children in developed countries. However, little is known about the epidemiology of childhood cancer in Ethiopia. This ...

    Authors: Amanuel Belay, Ahmed Ali, Wondimu Ayele, Mathewos Assefa, Ahmedin Jemal and Eva J. Kantelhardt
    Citation: BMC Cancer 2023 23:1261
  31. Locally advanced non-small cell lung cancer (NSCLC) with N1/N2 lymph node metastasis is challenging with poor survival. Neo-adjuvant chemo-immunotherapy has gained benefits in a proportion of these patients. H...

    Authors: Chengli Du, Yunhao Chen, Yuwei Zhou, Difang Zheng, Jiangang Zhao, Jie Tang, Yihe Wu and Zhengliang Tu
    Citation: BMC Cancer 2023 23:1260
  32. Endoscopic surgery can be used as the main treatment for advanced recurrent nasopharyngeal carcinoma (rNPC). However, there is a huge clinical controversy about the need for consolidated immunotherapy after su...

    Authors: Haoyuan Xu, Wanpeng Li, Huankang Zhang, Huan Wang, Li Hu, Yurong Gu and Dehui Wang
    Citation: BMC Cancer 2023 23:1259
  33. There is paucity of data regarding outcomes of children, adolescents and young adults (CAYA) patients with non-Hodgkin lymphoma (NHL) undergoing autologous stem cell transplantation (ASCT).

    Authors: Oren Pasvolsky, Roland L. Bassett, Sassine Ghanem, Branko Cuglievan, Priti Tewari, Chitra Hosing, Samer Srour, Jeremy Ramdial, Kris M. Mahadeo, Sajad Khazal, Demetrios Petropoulos, Uday Popat, Muzaffar Qazilbash, Partow Kebriaei, Richard Champlin, Elizabeth J. Shpall…
    Citation: BMC Cancer 2023 23:1258
  34. To explore the potential role of signal transducer and activator of transcription 5A (STAT5A) in the metastasis of breast cancer, and its mechanism of regulation underlying.

    Authors: Min-Na Chen, Ze-Xuan Fang, Zheng Wu, Jing-Wen Bai, Rong-Hui Li, Xiao-Fen Wen, Guo-Jun Zhang and Jing Liu
    Citation: BMC Cancer 2023 23:1257
  35. Qualitative research on cancer survivors’ need for comprehensive cancer survivorship care within the health care system is limited. Our study aimed to understand cancer survivors' and health professionals' exp...

    Authors: Su Jung Lee, Dal-Lae Jin, Young Ae Kim, Hyun-Ju Seo and Seok-Jun Yoon
    Citation: BMC Cancer 2023 23:1255

    The Correction to this article has been published in BMC Cancer 2024 24:29

  36. Glioblastoma multiforme (GBM) is recognized as the prevailing malignant and aggressive primary brain tumor, characterized by an exceedingly unfavorable prognosis. Cuproptosis, a recently identified form of pro...

    Authors: Lirui Dai, Peizhi Zhou, Liang Lyu and Shu Jiang
    Citation: BMC Cancer 2023 23:1249
  37. Existing literature suggests that tertiary lymphatic structure (TLS) is associated with the progression of cancer. However, the prognostic role of TLS in digestive system cancers remains controversial. This me...

    Authors: Hao Sun, Yuanyu Shi, Hailiang Ran, Junwei Peng, Qiongxian Li, Guiqing Zheng, Yandie He, Shuqing Liu, Wei Chang and Yuanyuan Xiao
    Citation: BMC Cancer 2023 23:1248
  38. Markers that can be used to evaluate the prognosis of patients with head and neck squamous cell carcinoma (HNSCC) remain undefined.

    Authors: Jiao Zhou, Sheng Wei, Xiumei Guo, Yanjun Huang, Yizheng Zhang, Yuming Hong, Xiaofang Chen, Ming Lu, Feng Zheng and Chaohui Zheng
    Citation: BMC Cancer 2023 23:1247
  39. Our study compares the outcomes of extensive spinal metastasis patients treated with Ultra-Long Construct Navigated Minimally Invasive Spine Surgery (UNMISS) with Adjuvant Radiotherapy to those receiving only ...

    Authors: Borriwat Santipas, Monchai Ruangchainikom, Sirichai Wilartratsami, Supachat Jiamamornrat, Nhathita Panatreswas and Panya Luksanapruksa
    Citation: BMC Cancer 2023 23:1246
  40. Cardiac Myxoma is a primary tumor of heart. Its origins, rarity of the occurrence of primary cardiac tumors and how it may be related to limited cardiac regenerative potential, are not yet entirely known. This...

    Authors: Ovais Shafi, Ghazia Siddiqui and Hassam A. Jaffry
    Citation: BMC Cancer 2023 23:1245
  41. An increasing number of small nucleolar RNA host genes (SNHGs) have been revealed to be dysregulated in lung cancer tissues, and abnormal expression of SNHGs is significantly correlated with the prognosis of l...

    Authors: Guo-yi Shen, Rong-zhi Huang, Shao-bin Yang, Rong-qiang Shen, Jian-li Gao and Yi Zhang
    Citation: BMC Cancer 2023 23:1243
  42. Despite the diverse genetic mutations in head and neck cancer, the chemotherapy outcome for this cancer has not improved for decades. It is urgent to select prognostic factors and therapeutic targets for oroph...

    Authors: Hae Chan Park, Hyojin Kim, Ji-Yeong Kim, Hye-Yeon Lee, Jinyi Lee, WonJae Cha, Soon-Hyun Ahn and Woo-Jin Jeong
    Citation: BMC Cancer 2023 23:1242

Featured videos

View featured videos from across the BMC-series journals